116 related articles for article (PubMed ID: 16626655)
21. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
[TBL] [Abstract][Full Text] [Related]
22. Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.
Berrendero F; Sánchez A; Cabranes A; Puerta C; Ramos JA; García-Merino A; Fernández-Ruiz J
Synapse; 2001 Sep; 41(3):195-202. PubMed ID: 11391780
[TBL] [Abstract][Full Text] [Related]
23. Atypical location of cannabinoid receptors in white matter areas during rat brain development.
Romero J; Garcia-Palomero E; Berrendero F; Garcia-Gil L; Hernandez ML; Ramos JA; Fernández-Ruiz JJ
Synapse; 1997 Jul; 26(3):317-23. PubMed ID: 9183820
[TBL] [Abstract][Full Text] [Related]
24. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
25. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cannabinoid-binding sites in zebrafish brain.
Rodriguez-Martin I; Marron Fernandez de Velasco E; Rodriguez RE
Neurosci Lett; 2007 Feb; 413(3):249-54. PubMed ID: 17178193
[TBL] [Abstract][Full Text] [Related]
27. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Hampson RE; Deadwyler SA; Childers SR
J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.
Basavarajappa BS; Hungund BL
J Neurosci Res; 2001 May; 64(4):429-36. PubMed ID: 11340650
[TBL] [Abstract][Full Text] [Related]
29. Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice.
Cabranes A; Pryce G; Baker D; Fernández-Ruiz J
Brain Res; 2006 Aug; 1107(1):199-205. PubMed ID: 16822488
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Selley DE; Stark S; Sim LJ; Childers SR
Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
[TBL] [Abstract][Full Text] [Related]
31. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
[TBL] [Abstract][Full Text] [Related]
32. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
Sim LJ; Selley DE; Childers SR
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174
[TBL] [Abstract][Full Text] [Related]
33. Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex.
Sim-Selley LJ; Vogt LJ; Vogt BA; Childers SR
Life Sci; 2002 Sep; 71(19):2217-26. PubMed ID: 12215369
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
[TBL] [Abstract][Full Text] [Related]
35. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
Breivogel CS; Sim LJ; Childers SR
J Pharmacol Exp Ther; 1997 Sep; 282(3):1632-42. PubMed ID: 9316881
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
Breivogel CS; Selley DE; Childers SR
J Biol Chem; 1998 Jul; 273(27):16865-73. PubMed ID: 9642247
[TBL] [Abstract][Full Text] [Related]
38. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.
Romero J; Berrendero F; Garcia-Gil L; de la Cruz P; Ramos JA; Fernández-Ruiz JJ
Neuroscience; 1998 Jun; 84(4):1075-83. PubMed ID: 9578396
[TBL] [Abstract][Full Text] [Related]
39. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
Mostany R; Pazos A; Castro ME
Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724
[TBL] [Abstract][Full Text] [Related]
40. Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.
Oliva JM; Ortiz S; Palomo T; Manzanares J
J Neurochem; 2003 Apr; 85(1):94-104. PubMed ID: 12641731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]